Jon Tremmel is listed as a director on 8 SEC Form D filings by 2 issuers between Feb 2009 and Jul 2018: ReShape Lifesciences Inc. (San Clemente, CA — other health care — 2009–2018; $61M reported sold to 41 investors) and NEVRO CORP (Menlo Park, CA — biotechnology — 2010–2011; $58.6M reported sold to 13 investors).
What this means 2 separate companies raised money with this person listed as director, over about 9 years. Across those companies the filings report $119.6M sold in total.
Public records searched: federal courts (CourtListener / RECAP), SEC enforcement releases, state securities regulators (AZ, CA, DE, TX, WA) — 6 court cases matching the name, 4 bankruptcy cases matching the name listed in Key records below.
What this means 10 records came back, including 3 court cases still open — open cases can take years and cost money. Each one is listed below with a link to the original document and a line saying why it matched. A name match is not proof it is the same person or company — read the why line and the document. Being sued or named in a release is an accusation, not a finding.
We compared 8 public filings for Jon Tremmel and found 10 differences: Form D filed 46 days after the first sale; No amendment in the last 12 months on an offering that may still be open; and more below.
What this means These are differences between the sponsor's own SEC filings — both values, dates and sources are listed in Key records, section 4. Most have ordinary explanations; ask the sponsor.